Aquestive Therapeutics, Inc. financial data

Symbol
AQST on Nasdaq
Location
Warren, NJ
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 04 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 412% % -32%
Quick Ratio 26% % -39%
Debt-to-equity -404% % -13%
Return On Equity 196% % 97%
Return On Assets -64% % -67%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 122,045,049 shares 23%
Common Stock, Shares, Outstanding 122,044,299 shares 34%
Entity Public Float $291,600,000 USD 41%
Common Stock, Value, Issued $122,000 USD 34%
Weighted Average Number of Shares Outstanding, Basic 106,926,528 shares 23%
Weighted Average Number of Shares Outstanding, Diluted 106,926,528 shares 23%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $44,545,000 USD -23%
Research and Development Expense $17,192,000 USD -15%
Costs and Expenses $115,596,000 USD 31%
Operating Income (Loss) $71,051,000 USD -131%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $83,784,000 USD -90%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $83,784,000 USD -90%
Earnings Per Share, Basic -0.78 USD/shares -53%
Earnings Per Share, Diluted -0.78 USD/shares -53%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $129,063,000 USD 66%
Inventory, Net $6,169,000 USD 2.1%
Assets, Current $149,269,000 USD 69%
Property, Plant and Equipment, Net $3,893,000 USD 2.5%
Operating Lease, Right-of-Use Asset $4,621,000 USD -11%
Other Assets, Noncurrent $2,642,000 USD -37%
Assets $160,425,000 USD 58%
Accounts Payable, Current $29,862,000 USD 190%
Employee-related Liabilities, Current $3,707,000 USD -22%
Accrued Liabilities, Current $5,029,000 USD -15%
Contract with Customer, Liability, Current $1,092,000 USD 4.2%
Liabilities, Current $47,608,000 USD 152%
Long-term Debt and Lease Obligation $27,519,000 USD -15%
Contract with Customer, Liability, Noncurrent $19,390,000 USD -3.1%
Operating Lease, Liability, Noncurrent $4,337,000 USD -13%
Other Liabilities, Noncurrent $7,269,000 USD 204%
Liabilities $194,087,000 USD 20%
Retained Earnings (Accumulated Deficit) $446,998,000 USD -23%
Stockholders' Equity Attributable to Parent $33,662,000 USD 44%
Liabilities and Equity $160,425,000 USD 58%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,400,000 USD -125%
Net Cash Provided by (Used in) Financing Activities $20,646,000 USD -75%
Net Cash Provided by (Used in) Investing Activities $135,000 USD -366%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 122,044,299 shares 34%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,889,000 USD -104%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $121,169,000 USD 69%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,003,000 USD -32%
Deferred Tax Assets, Valuation Allowance $113,174,000 USD 20%
Deferred Tax Assets, Gross $114,921,000 USD 21%
Operating Lease, Liability $4,968,000 USD -9.3%
Depreciation $548,000 USD -14%
Payments to Acquire Property, Plant, and Equipment $135,000 USD 366%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $83,784,000 USD -90%
Lessee, Operating Lease, Liability, to be Paid $7,759,000 USD -14%
Property, Plant and Equipment, Gross $47,914,000 USD 1.3%
Operating Lease, Liability, Current $631,000 USD 24%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,346,000 USD 2.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,318,000 USD 2.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,791,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,180,000 USD -12%
Deferred Tax Assets, Operating Loss Carryforwards $48,764,000 USD 41%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,000,000 USD -15%
Additional Paid in Capital $413,214,000 USD 36%
Amortization of Intangible Assets $0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $7,624,000 USD 7.4%
Interest Expense $9,092,000 USD 49%